Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis

By F. Petrelli, G. Tomasello, K. Borgonovo, M. Ghidini, L. Turati, P. Dallera, R. Passalacqua, G. Sgroi, S. Barni. JAMA Oncology, 2017

705 citations recorded by the source corpus.

Subfields: Epidemiology, Oncology

View Paper: https://www.semanticscholar.org/paper/d89dfe6d1d04fcd6ebcaeec29090ab98c9f4f4d2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. R. Siegel
2. A. Jemal
3. D. Arnold

In Oncology

1. R. Siegel
2. A. Jemal
3. Fortunato Ciardiello
4. K. Miller
5. F. Bray
6. J. Ferlay

Citations in the corpus

• Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials † (2017, result): “Discussion/summary of the evidence In relation to the prognostic value, the individual trial data for all six trials showed treatment outcomes to be better in patients with left-sided tumours than in those with right-sided tumours, confirming the evidence from previous studies [16, 19–21] and a rece”
• Colorectal cancer statistics, 2023 (2023, methodology): “compared with left‐sided cancers independent of histological and molecular characteristics.(90,91) However, the largest sex disparity in 5‐ year survival is also for left‐sided tumors at 66% in men versus 68% in women for distal colon cancer and 67% versus 70%, respectively, for rectal cancer.”